FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37327264> ?p ?o ?g. }

• Q37327264 description "article científic" @default.
• Q37327264 description "article scientifique" @default.
• Q37327264 description "articolo scientifico" @default.
• Q37327264 description "artigo científico" @default.
• Q37327264 description "artículu científicu espublizáu en 2013" @default.
• Q37327264 description "bilimsel makale" @default.
• Q37327264 description "scientific article published on 20 June 2013" @default.
• Q37327264 description "vedecký článok" @default.
• Q37327264 description "vetenskaplig artikel" @default.
• Q37327264 description "videnskabelig artikel" @default.
• Q37327264 description "vědecký článek" @default.
• Q37327264 description "wetenschappelijk artikel" @default.
• Q37327264 description "wissenschaftlicher Artikel" @default.
• Q37327264 description "наукова стаття, опублікована в червні 2013" @default.
• Q37327264 description "научни чланак" @default.
• Q37327264 description "مقالة علمية نشرت في 20 يونيو 2013" @default.
• Q37327264 name "Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use." @default.
• Q37327264 name "Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use." @default.
• Q37327264 name "Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use." @default.
• Q37327264 type Item @default.
• Q37327264 label "Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use." @default.
• Q37327264 label "Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use." @default.
• Q37327264 label "Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use." @default.
• Q37327264 prefLabel "Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use." @default.
• Q37327264 prefLabel "Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use." @default.
• Q37327264 prefLabel "Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use." @default.
• Q37327264 P1433 Q37327264-ABBCB98E-21FD-44D1-B8C1-D3FB165257BE @default.
• Q37327264 P1476 Q37327264-49DCFD51-FE5B-445F-A69D-4AEEA10B5539 @default.
• Q37327264 P2093 Q37327264-02464542-E295-42EE-9B3B-A5E1D4565156 @default.
• Q37327264 P2093 Q37327264-403EE840-CBA2-45D7-AE38-20D51AA714EB @default.
• Q37327264 P2093 Q37327264-7440DF94-2775-4490-9E5A-BDD6EDA25873 @default.
• Q37327264 P2860 Q37327264-01CD676B-D1A1-418E-B79E-66B1CEAD5640 @default.
• Q37327264 P2860 Q37327264-09188155-A58A-4600-AC05-F37C83855581 @default.
• Q37327264 P2860 Q37327264-0F1711DA-B9E6-4D1A-BFFA-C446B709E59B @default.
• Q37327264 P2860 Q37327264-1B95F616-BC5F-452D-8909-7D9BA13159BF @default.
• Q37327264 P2860 Q37327264-1D3F0CE2-BED1-4794-A3EC-C5F19638BBA0 @default.
• Q37327264 P2860 Q37327264-268DAE9D-0B9F-421E-8C80-AB311D57483C @default.
• Q37327264 P2860 Q37327264-2815693B-CE19-498E-A478-4240CA2312EF @default.
• Q37327264 P2860 Q37327264-2A83C9CC-E3E4-4F67-A8C4-520F345AAE08 @default.
• Q37327264 P2860 Q37327264-2D55DF33-E5DC-4A5E-B5E3-2EE441DED979 @default.
• Q37327264 P2860 Q37327264-41F673D6-5EA8-419B-BCB9-B89D565285DF @default.
• Q37327264 P2860 Q37327264-48DC0A00-7EFF-494B-A530-F147E2372805 @default.
• Q37327264 P2860 Q37327264-4A4DD145-9854-49E3-9D2D-D32EFACF57C8 @default.
• Q37327264 P2860 Q37327264-65F1C074-C64F-43D2-85D4-0EDC01F2BBD0 @default.
• Q37327264 P2860 Q37327264-6CD3F6A7-3928-4518-84C8-049B9D6716A9 @default.
• Q37327264 P2860 Q37327264-7B8FC8D8-19A1-4D8F-B72C-87F1DBD8BAAF @default.
• Q37327264 P2860 Q37327264-7EF75CEE-0FCC-42C8-9B6F-E6B679AB8F5D @default.
• Q37327264 P2860 Q37327264-90B5E684-40EC-476A-99A7-594CCC4AF163 @default.
• Q37327264 P2860 Q37327264-9807CEDE-AE45-4532-873F-B4EBA3D4A230 @default.
• Q37327264 P2860 Q37327264-9CDA2408-3B37-4A9A-AE31-4D38B0DB0D4A @default.
• Q37327264 P2860 Q37327264-AC0A8C38-9DFD-4C5D-8F8F-B1CA82ED164E @default.
• Q37327264 P2860 Q37327264-B21F8FF4-3AB9-4D8A-8328-0E3515A7B6BF @default.
• Q37327264 P2860 Q37327264-B2CF3CAC-A36B-43EB-92CD-4AFE76CF0914 @default.
• Q37327264 P2860 Q37327264-BDAF493E-7A86-4911-97AE-1A9ACCB54743 @default.
• Q37327264 P2860 Q37327264-C2609E81-920A-4D7F-B26C-4F62AE6C663A @default.
• Q37327264 P2860 Q37327264-C85E72B6-6677-4EAD-887D-7D7CEC2E31E8 @default.
• Q37327264 P2860 Q37327264-CFB48D4B-922A-44DA-AB70-5C76D4A722FE @default.
• Q37327264 P2860 Q37327264-D10267BE-0790-4113-BEDA-279BE02990D8 @default.
• Q37327264 P2860 Q37327264-EB85A0B0-B0EE-4FE1-8891-00392F0B88C3 @default.
• Q37327264 P2860 Q37327264-EE51628D-1FB1-4398-B77F-63B12B6F8547 @default.
• Q37327264 P2860 Q37327264-EE72E28F-A133-4232-BB3C-ECBFF82B51ED @default.
• Q37327264 P2860 Q37327264-F5BC0555-A073-4E1E-B1B3-581596E517E2 @default.
• Q37327264 P2860 Q37327264-FCD579A4-6AB8-4AEF-8F73-60969874DF36 @default.
• Q37327264 P304 Q37327264-B52CBB08-9034-40EC-BA87-289717292281 @default.
• Q37327264 P31 Q37327264-774F5564-A9CB-4972-90E0-4D391A41BA13 @default.
• Q37327264 P356 Q37327264-BEEB653C-3850-410B-A5BC-1C6EEDDAF5DB @default.
• Q37327264 P433 Q37327264-6236C817-9D0B-4B74-96E9-85022AD1265B @default.
• Q37327264 P478 Q37327264-68F66A51-BC97-42B6-94EB-7127AC718E06 @default.
• Q37327264 P50 Q37327264-EBF1944E-AAB8-4CA8-931A-204730309B68 @default.
• Q37327264 P577 Q37327264-ADC1064F-9324-4D20-A46C-BB2E56E4E11C @default.
• Q37327264 P5875 Q37327264-42C0C17B-DF76-4F00-8043-0AC365A600BA @default.
• Q37327264 P698 Q37327264-0124AA39-4279-4846-A58F-37CDF8C17072 @default.
• Q37327264 P932 Q37327264-7AE433A4-C27C-4886-93C9-F7A8024EB4CE @default.
• Q37327264 P356 PDIA.2013.35619 @default.
• Q37327264 P698 24278069 @default.
• Q37327264 P1433 Q22965552 @default.
• Q37327264 P1476 "Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use." @default.
• Q37327264 P2093 "Anna Szewczyk" @default.
• Q37327264 P2093 "Katarzyna Gutfreund" @default.
• Q37327264 P2093 "Wojciech Bienias" @default.
• Q37327264 P2860 Q33635664 @default.
• Q37327264 P2860 Q34136595 @default.
• Q37327264 P2860 Q34286720 @default.
• Q37327264 P2860 Q34504258 @default.
• Q37327264 P2860 Q34668921 @default.
• Q37327264 P2860 Q35653289 @default.
• Q37327264 P2860 Q36153370 @default.
• Q37327264 P2860 Q36201776 @default.
• Q37327264 P2860 Q36222741 @default.
• Q37327264 P2860 Q36817021 @default.
• Q37327264 P2860 Q36940038 @default.
• Q37327264 P2860 Q39355978 @default.
• Q37327264 P2860 Q40565484 @default.
• Q37327264 P2860 Q43639646 @default.
• Q37327264 P2860 Q44006693 @default.
• Q37327264 P2860 Q44133222 @default.
• Q37327264 P2860 Q44513075 @default.
• Q37327264 P2860 Q44804913 @default.
• Q37327264 P2860 Q44833282 @default.
• Q37327264 P2860 Q44922711 @default.

• next